These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22479467)

  • 1. Identification of novel Mt-Guab2 inhibitor series active against M. tuberculosis.
    Usha V; Hobrath JV; Gurcha SS; Reynolds RC; Besra GS
    PLoS One; 2012; 7(3):e33886. PubMed ID: 22479467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel diphenyl urea inhibitors of Mt-GuaB2 active against Mycobacterium tuberculosis.
    Usha V; Gurcha SS; Lovering AL; Lloyd AJ; Papaemmanouil A; Reynolds RC; Besra GS
    Microbiology (Reading); 2011 Jan; 157(Pt 1):290-299. PubMed ID: 21081761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds.
    Makowska-Grzyska M; Kim Y; Gorla SK; Wei Y; Mandapati K; Zhang M; Maltseva N; Modi G; Boshoff HI; Gu M; Aldrich C; Cuny GD; Hedstrom L; Joachimiak A
    PLoS One; 2015; 10(10):e0138976. PubMed ID: 26440283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
    Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis.
    Singh V; Donini S; Pacitto A; Sala C; Hartkoorn RC; Dhar N; Keri G; Ascher DB; Mondésert G; Vocat A; Lupien A; Sommer R; Vermet H; Lagrange S; Buechler J; Warner DF; McKinney JD; Pato J; Cole ST; Blundell TL; Rizzi M; Mizrahi V
    ACS Infect Dis; 2017 Jan; 3(1):5-17. PubMed ID: 27726334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis.
    Park Y; Pacitto A; Bayliss T; Cleghorn LA; Wang Z; Hartman T; Arora K; Ioerger TR; Sacchettini J; Rizzi M; Donini S; Blundell TL; Ascher DB; Rhee K; Breda A; Zhou N; Dartois V; Jonnala SR; Via LE; Mizrahi V; Epemolu O; Stojanovski L; Simeons F; Osuna-Cabello M; Ellis L; MacKenzie CJ; Smith AR; Davis SH; Murugesan D; Buchanan KI; Turner PA; Huggett M; Zuccotto F; Rebollo-Lopez MJ; Lafuente-Monasterio MJ; Sanz O; Diaz GS; Lelièvre J; Ballell L; Selenski C; Axtman M; Ghidelli-Disse S; Pflaumer H; Bösche M; Drewes G; Freiberg GM; Kurnick MD; Srikumaran M; Kempf DJ; Green SR; Ray PC; Read K; Wyatt P; Barry CE; Boshoff HI
    ACS Infect Dis; 2017 Jan; 3(1):18-33. PubMed ID: 27704782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazole-linked inhibitors of inosine monophosphate dehydrogenase from human and Mycobacterium tuberculosis.
    Chen L; Wilson DJ; Xu Y; Aldrich CC; Felczak K; Sham YY; Pankiewicz KW
    J Med Chem; 2010 Jun; 53(12):4768-78. PubMed ID: 20491506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-Based Approach to Targeting Inosine-5'-monophosphate Dehydrogenase (IMPDH) from Mycobacterium tuberculosis.
    Trapero A; Pacitto A; Singh V; Sabbah M; Coyne AG; Mizrahi V; Blundell TL; Ascher DB; Abell C
    J Med Chem; 2018 Apr; 61(7):2806-2822. PubMed ID: 29547284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Structure-Activity relationship of 1-(5-isoquinolinesulfonyl)piperazine analogues as inhibitors of Mycobacterium tuberculosis IMPDH.
    Singh V; Pacitto A; Donini S; Ferraris DM; Boros S; Illyés E; Szokol B; Rizzi M; Blundell TL; Ascher DB; Pato J; Mizrahi V
    Eur J Med Chem; 2019 Jul; 174():309-329. PubMed ID: 31055147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel inhibitors of Mycobacterium tuberculosis GuaB2 identified by a target based high-throughput phenotypic screen.
    Cox JA; Mugumbate G; Del Peral LV; Jankute M; Abrahams KA; Jervis P; Jackenkroll S; Perez A; Alemparte C; Esquivias J; Lelièvre J; Ramon F; Barros D; Ballell L; Besra GS
    Sci Rep; 2016 Dec; 6():38986. PubMed ID: 27982051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cofactor-binding mode in bacterial IMP dehydrogenases explains inhibitor selectivity.
    Makowska-Grzyska M; Kim Y; Maltseva N; Osipiuk J; Gu M; Zhang M; Mandapati K; Gollapalli DR; Gorla SK; Hedstrom L; Joachimiak A
    J Biol Chem; 2015 Feb; 290(9):5893-911. PubMed ID: 25572472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid.
    Digits JA; Hedstrom L
    Biochemistry; 1999 Nov; 38(46):15388-97. PubMed ID: 10563825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.
    Chacko S; Boshoff HIM; Singh V; Ferraris DM; Gollapalli DR; Zhang M; Lawson AP; Pepi MJ; Joachimiak A; Rizzi M; Mizrahi V; Cuny GD; Hedstrom L
    J Med Chem; 2018 Jun; 61(11):4739-4756. PubMed ID: 29746130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5'-monophosphate dehydrogenase: implications on enzyme mechanism.
    Hedstrom L; Wang CC
    Biochemistry; 1990 Jan; 29(4):849-54. PubMed ID: 1971185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of inosine 5'-monophosphate dehydrogenase by the antiviral agent 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide 5'-monophosphate.
    Wang W; Papov VV; Minakawa N; Matsuda A; Biemann K; Hedstrom L
    Biochemistry; 1996 Jan; 35(1):95-101. PubMed ID: 8555204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
    Sintchak MD; Nimmesgern E
    Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
    Barnes BJ; Eakin AE; Izydore RA; Hall IH
    Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
    Goldman RC
    Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus.
    Huete-Pérez JA; Wu JC; Whitby FG; Wang CC
    Biochemistry; 1995 Oct; 34(42):13889-94. PubMed ID: 7577983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure at 2.4 A resolution of Borrelia burgdorferi inosine 5'-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6.
    McMillan FM; Cahoon M; White A; Hedstrom L; Petsko GA; Ringe D
    Biochemistry; 2000 Apr; 39(15):4533-42. PubMed ID: 10758003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.